Nature Biotechnology Podcast

David Baltimore, president emeritus of the California Institute of Technology, discusses his parents moving him from New York City to Great Neck, Long Island, as a child; his initial interest in animal virology; and getting that Nobel call from Sweden.  See acast.com/privacy for privacy and opt-out information.

Tom Maniatis is a founder of Kallyope, and head of the Maniatis lab at Columbia University. Among other things, he's founded several biotechs and authored a manual nicknamed 'the bible of cloning.' His conversation with Nature Biotechnology covers being the first in his family to go to college, the moratorium on recombinant DNA research in Cambridge, Massachusetts, and his long relationship with Jim Watson at Cold Spring Harbor.  See acast.com/privacy for privacy and opt-out information.

Daniel Cohen is chairman and CEO of Pharnext. He was also co-founder of CEPH, Genethon and Millennium, and an early leader in the genomics field. His talk with Nature Biotechnology covers the industrialization of genomic sequencing, his part in founding Millennium and why the conductor has the most difficult job in an orchestra.  See acast.com/privacy for privacy and opt-out information.

James Wilson is the director of the Gene Therapy Program at the University of Pennsylvania. He is also a founder and chief scientific advisor at Regenx Bio, as well as founder and chairman of scientific advisory council at Dimension Therapeutics. Wilson's conversation covers his love of motocross racing, the triumphs and tribulation of gene therapy (including the Jesse Gelsinger tragedy), and the future of drug pricing.  See acast.com/privacy for privacy and opt-out information.

Bill Rutter is founder, chairman and CEO of Synergenics, which manages a consortium of biotech companies. He was also a founder of Chiron and is credited with bringing the University of California at San Francisco to its prominent position in life sciences research. His discussion with Nature Biotechnology covers building out the labs at UCSF, sequencing the hepatitis C virus and his short stint in the Navy.  See acast.com/privacy for privacy and opt-out information.

Stan Crooke is the founder, chairman and CEO of Isis Pharmaceuticals. Nature Biotechnology spoke with Crooke about his troubled youth, the crests and valleys of antisense, and the skills needed to be a good leader.  See acast.com/privacy for privacy and opt-out information.

Rachel King is president and CEO of GlycoMimetics and former chairwoman of the Biotechnology Innovation Organization. Talking with Nature Biotechnology, King discusses gene therapy, how a CEO handles layoffs and growing up with chickens.  See acast.com/privacy for privacy and opt-out information.

Colin Goddard is former CEO of OSI Pharmaceuticals, and current chairman and CEO of Coferon. His conversation with Nature Biotechnology details the history behind OSI's blockbuster drug Tarceva (erlotinib), the benefits of having a British accent in the United States and how to survive a hostile takeover.  See acast.com/privacy for privacy and opt-out information.

Kari Stefansson's conversation with Nature Biotechnology covers the founding of deCODE, his love for literature (and his favorite poet), plus his encounter with the tortured chess grandmaster Bobby Fischer.  See acast.com/privacy for privacy and opt-out information.

Carl Feldbaum was the founding president of the Biotechnology Industry Organization (BIO), and he is the current chairman of the Life Sciences Foundation. His podcast conversation with Nature Biotechnology touches on his assistance in prosecuting Watergate, his visit to Saddam Hussein's palace and how he built BIO from the ground up.  See acast.com/privacy for privacy and opt-out information.

Daphne Zohar is the founder, CEO and managing partner at PureTech, a venture creation company with a new approach to building biotechs, and she sits on the board of several life science firms. Her conversation with Nature Biotechnology covers starting her first company (in high school), the usefulness of Bioentrepreneur courses, and women in venture capital. (Updated February 6, 2015).  See acast.com/privacy for privacy and opt-out information.

Mary Tanner details the Amgen-Immunex buyout, defines 'wildcatting' and suggests the years in which children most need a parent around the house.  See acast.com/privacy for privacy and opt-out information.

Anthony Davies discusses the past, present and future of stem cell therapies.  See acast.com/privacy for privacy and opt-out information.

Julian Davies takes us through his long research career in Madison, Wisconsin; Paris and Geneva. He also discusses wrecking his motorcycle and how he met his wife.  See acast.com/privacy for privacy and opt-out information.

Leroy Hood talks through the founding of Applied Biosystems, the beginnings of the Human Genome Project and what drew him to mountain climbing.  See acast.com/privacy for privacy and opt-out information.

Nature Biotechnology talked to West about his initial love for physics, scoring the first funding for Geron and the future of regenerative medicine.  See acast.com/privacy for privacy and opt-out information.

Nature Biotechnology spoke to Harvey Berger about developing Iclusig, the difference between managing a patient's health and running a company, and how a public entity deals with bad news.  See acast.com/privacy for privacy and opt-out information.

George Yancopoulos talks about the scientific foundation at Regeneron, upholding the family name and giving back through teaching.  See acast.com/privacy for privacy and opt-out information.

Una Ryan discusses the biotech East Coast vs. West; life in Oxford, UK; and her initial foray into industry via a job at Monsanto.  See acast.com/privacy for privacy and opt-out information.

William A. Haseltine talks about his time at HGS, the future of genomics in drug discovery and how innovation might be funded going forward.  See acast.com/privacy for privacy and opt-out information.